🔴 ProMIS Neurosciences is trading 6.37% down today after 14.64% gain on September 9

ProMIS Neurosciences is trading 6.37% down at $13.45 amid a weaker market backdrop, with the Nasdaq Composite down 0.80% and the S&P 500 down 0.49%.

• Shares gained 14.64% on September 9 after management highlighted zero ARIA-E cases and favorable blinded biomarker trends for PMN310 at the Cantor conference.
• Full 12-month data remain expected in the first quarter of 2027.